Skip to Content

Home infusion: Bioscrip to buy HomeChoice Partners

Home infusion: Bioscrip to buy HomeChoice Partners

EDEN PRAIRIE, Minn. - BioScrip, a specialty pharmacy services provider based here, will acquire HomeChoice Partners for $70 million, in a move designed to strengthen its home infusion services, according to multiple reports. HomeChoice is an alternate-site infusion pharmacy services provider. The acquisition follows BioScrip's July purchase of InfuScience, also an alternate-site provider of home infusion services. Revenue for home infusion services have spiked 39.5% in the last reported quarter, according to Zacks, an investment research website. BioScrip expects to close the deal in the first quarter of 2013.

Comments

To comment on this post, please log in to your account or set up an account now.